These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8633373)

  • 1. The effect of pravastatin on acute rejection after kidney transplantation--a pilot study.
    Katznelson S; Wilkinson AH; Kobashigawa JA; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Cohen AH; Teraski PI
    Transplantation; 1996 May; 61(10):1469-74. PubMed ID: 8633373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin.
    Imagawa DK; Dawson S; Holt CD; Kirk PS; Kaldas FM; Shackleton CR; Seu P; Rudich SM; Kinkhabwala MM; Martin P; Goldstein LI; Murray NG; Terasaki PI; Busuttil RW
    Transplantation; 1996 Oct; 62(7):934-42. PubMed ID: 8878387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reassuring effect of pravastatin on natural killer cell activity in stable renal transplant patients.
    Vaessen LM; van Miert PP; van Gelder T; Ijzermans JN; Weimar W
    Transplantation; 2001 Apr; 71(8):1175-9. PubMed ID: 11374422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients.
    Penson MG; Fricker FJ; Thompson JR; Harker K; Williams BJ; Kahler DA; Schowengerdt KO
    J Heart Lung Transplant; 2001 Jun; 20(6):611-8. PubMed ID: 11404165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pravastatin on outcomes after cardiac transplantation.
    Kobashigawa JA; Katznelson S; Laks H; Johnson JA; Yeatman L; Wang XM; Chia D; Terasaki PI; Sabad A; Cogert GA
    N Engl J Med; 1995 Sep; 333(10):621-7. PubMed ID: 7637722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pravastatin in heart transplant recipients: implications of Kobashigawa et al.
    Gotto AM
    Curr Opin Lipidol; 1995 Dec; 6(6):341-3. PubMed ID: 8750244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A.
    Park JW; Siekmeier R; Merz M; Krell B; Harder S; März W; Seidel D; Schüler S; Gross W
    Int J Clin Pharmacol Ther; 2002 Oct; 40(10):439-50. PubMed ID: 12395976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression.
    Katznelson S; Kobashigawa JA
    Kidney Int Suppl; 1995 Dec; 52():S112-5. PubMed ID: 8587272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
    Seipelt IM; Crawford SE; Rodgers S; Backer C; Mavroudis C; Seipelt RG; Pahl E
    J Heart Lung Transplant; 2004 Mar; 23(3):317-22. PubMed ID: 15019641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA; Hricik DE; Brinker K; Grinyo JM; Schena FP;
    Transplantation; 2002 Dec; 74(11):1560-7. PubMed ID: 12490789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses.
    Olbricht C; Wanner C; Eisenhauer T; Kliem V; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Clin Pharmacol Ther; 1997 Sep; 62(3):311-21. PubMed ID: 9333107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD; Simon M; Wachs ME; Chan L; Nolan C; Kam I
    Transplantation; 1997 Dec; 64(12):1695-700. PubMed ID: 9422404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study describing the use of pravastatin in pediatric renal transplant recipients.
    Butani L; Pai MV; Makker SP
    Pediatr Transplant; 2003 Jun; 7(3):179-84. PubMed ID: 12756041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Utility of pravastin in cardiac transplant dyslipidemia].
    Martínez-Dolz L; Almenar Bonet L; Arnau Vives MA; Rueda Soriano J; Osa Sáez A; Dicenta Gisbert F; Palencia Pérez M
    Rev Clin Esp; 2002 Sep; 202(9):489-91. PubMed ID: 12236939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.
    Schulak JA; Mayes JT; Moritz CE; Hricik DE
    Transplantation; 1990 Feb; 49(2):327-32. PubMed ID: 2407003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of simvastatin and pravastatin on acute rejection episodes in renal transplant patients.
    Tuncer M; Süleymanlar G; Ersoy FF; Yakupoğlu G
    Transplant Proc; 2000 May; 32(3):622-5. PubMed ID: 10812143
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of pravastatin and lovastatin in renal transplant patients receiving cyclosporine.
    Kliem V; Wanner C; Eisenhauer T; Olbricht CJ; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Transplant Proc; 1996 Dec; 28(6):3126-8. PubMed ID: 8962211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.